CRMD Cormedix Inc.

$8.65 -0.35%

Healthcare · Pharmaceutical Preparations

Cormedix Inc. (CRMD) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $679 million. Shares last traded at $8.65, 50.3% below their 52-week high. Over the past year the stock is down 37.8%. CRMD trades at a price-to-earnings ratio of 4.16, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 52.3%, above the peer median of -0.1%. Revenue grew 617.0% year over year.

Market Cap

$679M

Shares Out

78.5M

EPS (TTM)

$3.28

P/E Ratio

2.64

P/S Ratio

2.18

P/B Ratio

1.55

Dividend / Share

—

Dividend Yield

—

52-Week High

$17.40

52-Week Low

$6.13

Volume

169,506

Avg Vol (3m)

75,833.048

Performance

-3.35%

+10.61%

+37.30%

-24.32%

YTD

-28.89%

-37.77%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

59.12

SMA (50)

$7.95

SMA (200)

$9.17

Price vs SMA50

+8.76%

Price vs SMA200

-5.65%

ATR (14)

$0.31

Financials

Revenue

$312M

Net Income

$163M

Gross Margin

88.5%

Operating Margin

48.2%

Net Margin

52.3%

Return on Equity

37.3%

Return on Assets

20.0%

Current Ratio

2.98

Debt / Equity

0.87

Revenue Growth (YoY)

+617.0%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.43	2026-05-14
FY 2025	$2.04	2026-03-05
Q3 2025	$1.97	2025-11-12
Q2 2025	$0.58	2025-08-07
Q1 2026	$0.30	2026-05-14
FY 2025	$-0.30	2026-03-05

Full earnings history →

Pharmaceutical Preparations peers

CRMD vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

4.16 / 16.82 med

-75% discount

P/S vs peers

2.18 / 3.54 med

-38% discount

Net margin vs peers

52.3% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.